Inside Johnson & Johnson's Earnings Beat

Johnson & Johnson beat analysts’ estimates for third-quarter profit as a lower tax rate helped the world’s biggest maker of health-care products overcome slightly weaker-than-projected sales for key drugs such as Remicade. Gabelli & Co.'s Jeff Jonas and Bloomberg's Cynthia Koons weigh in on "Bloomberg Markets." Jonas owns no stock in J&J. (Source: Bloomberg)

Crucial Perspective Sees Turnaround for Cathay in 2018
33:10 - Corrine Png, chief executive officer and founder of Crucial Perspective, discusses Cathay Pacific's earnings and her outlook for the airlines future. She speaks on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
  • Tencent Posts Record 2Q Profit
  • Alibaba Earnings Preview: Will Revenue Really Jump 49%?
  • Full Show: Bloomberg Technology (08/16)